{"id":251673,"date":"2021-05-15T00:00:00","date_gmt":"2021-05-15T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidcv0041-biopharma-acute-heart-failure-epidemiology-middle-east\/"},"modified":"2026-03-31T10:43:19","modified_gmt":"2026-03-31T10:43:19","slug":"epidcv0041-biopharma-acute-heart-failure-epidemiology-middle-east-africa","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcv0041-biopharma-acute-heart-failure-epidemiology-middle-east-africa\/","title":{"rendered":"Acute Heart Failure &#8211; Epidemiology &#8211; Middle East &#038; Africa"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of acute heart failure (<abbr title=\"acute heart failure\">AHF<\/abbr>) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the hospitalization rate of <abbr title=\"acute heart failure\">AHF<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this content.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"acute heart failure\">AHF<\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>Of all <abbr title=\"acute heart failure\">AHF<\/abbr> hospitalizations, how many in each of the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"acute heart failure\">AHF<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>In addition to the total number of cases of <abbr data-abbreviation-entity=\"6452\" title=\"acute heart failure\">AHF<\/abbr> for each forecast year, Clarivate Epidemiology provides at least 10 years of forecast data for the following subpopulations:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed events: <abbr title=\"acute heart failure\">AHF<\/abbr> primary diagnoses with hypotension.<\/li>\n<li>Diagnosed events: <abbr title=\"acute heart failure\">AHF<\/abbr> primary diagnoses with no hypotension.<\/li>\n<li>Diagnosed events: <abbr title=\"acute heart failure\">AHF<\/abbr> secondary diagnoses with hypotension.<\/li>\n<li>Diagnosed events: <abbr title=\"acute heart failure\">AHF<\/abbr> secondary diagnoses with no hypotension.<\/li>\n<li>Diagnosed events: <abbr title=\"acute heart failure\">AHF<\/abbr> by hypertension status.<\/li>\n<li>Diagnosed events: <abbr title=\"acute heart failure\">AHF<\/abbr> by reduced versus preserved or mid-range ejection fraction.<\/li>\n<li>Diagnosed events: <abbr title=\"acute heart failure\">AHF<\/abbr> by drug-treatment status.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-251673","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-acute-heart-failure","biopharma-therapy-areas-cardiovascular","biopharma-therapy-areas-heart-failure","biopharma-product-epidemiology","biopharma-geography-middle-east-africa","biopharma-date-950"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251673\/revisions"}],"predecessor-version":[{"id":576406,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251673\/revisions\/576406"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}